COVID-19 Impact on Global Hodgkin's Lymphoma Drugs Market Size, Status and Forecast 2020-2026

July 2020 | 96 pages | ID: C4904B312015EN
QYResearch

Abstracts

This report focuses on the global Hodgkin's Lymphoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hodgkin's Lymphoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Pfizer
• Roche
• Merck
• Bristol-Myers Squibb
• Ono Pharmaceutical
• Seattle Genetics

Market segment by Type, the product can be split into

• Targeted Therapy
• Chemotherapy

Market segment by Application, split into

• Hospitals
• Clinics
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Hodgkin's Lymphoma Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Hodgkin's Lymphoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Hodgkin's Lymphoma Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hodgkin's Lymphoma Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Hodgkin's Lymphoma Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Targeted Therapy
  1.4.3 Chemotherapy
1.5 Market by Application
  1.5.1 Global Hodgkin's Lymphoma Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Clinics
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Hodgkin's Lymphoma Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Hodgkin's Lymphoma Drugs Industry
    1.6.1.1 Hodgkin's Lymphoma Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Hodgkin's Lymphoma Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Hodgkin's Lymphoma Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Hodgkin's Lymphoma Drugs Market Perspective (2015-2026)
2.2 Hodgkin's Lymphoma Drugs Growth Trends by Regions
  2.2.1 Hodgkin's Lymphoma Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Hodgkin's Lymphoma Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Hodgkin's Lymphoma Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Hodgkin's Lymphoma Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Hodgkin's Lymphoma Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Hodgkin's Lymphoma Drugs Players by Market Size
  3.1.1 Global Top Hodgkin's Lymphoma Drugs Players by Revenue (2015-2020)
  3.1.2 Global Hodgkin's Lymphoma Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Hodgkin's Lymphoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hodgkin's Lymphoma Drugs Market Concentration Ratio
  3.2.1 Global Hodgkin's Lymphoma Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Hodgkin's Lymphoma Drugs Revenue in 2019
3.3 Hodgkin's Lymphoma Drugs Key Players Head office and Area Served
3.4 Key Players Hodgkin's Lymphoma Drugs Product Solution and Service
3.5 Date of Enter into Hodgkin's Lymphoma Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Hodgkin's Lymphoma Drugs Historic Market Size by Type (2015-2020)
4.2 Global Hodgkin's Lymphoma Drugs Forecasted Market Size by Type (2021-2026)

5 HODGKIN'S LYMPHOMA DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)
5.2 Global Hodgkin's Lymphoma Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Hodgkin's Lymphoma Drugs Market Size (2015-2020)
6.2 Hodgkin's Lymphoma Drugs Key Players in North America (2019-2020)
6.3 North America Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
6.4 North America Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Hodgkin's Lymphoma Drugs Market Size (2015-2020)
7.2 Hodgkin's Lymphoma Drugs Key Players in Europe (2019-2020)
7.3 Europe Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
7.4 Europe Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Hodgkin's Lymphoma Drugs Market Size (2015-2020)
8.2 Hodgkin's Lymphoma Drugs Key Players in China (2019-2020)
8.3 China Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
8.4 China Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Hodgkin's Lymphoma Drugs Market Size (2015-2020)
9.2 Hodgkin's Lymphoma Drugs Key Players in Japan (2019-2020)
9.3 Japan Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
9.4 Japan Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Hodgkin's Lymphoma Drugs Market Size (2015-2020)
10.2 Hodgkin's Lymphoma Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Hodgkin's Lymphoma Drugs Market Size (2015-2020)
11.2 Hodgkin's Lymphoma Drugs Key Players in India (2019-2020)
11.3 India Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
11.4 India Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Hodgkin's Lymphoma Drugs Market Size (2015-2020)
12.2 Hodgkin's Lymphoma Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020)
12.4 Central & South America Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Hodgkin's Lymphoma Drugs Introduction
  13.1.4 Pfizer Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche Hodgkin's Lymphoma Drugs Introduction
  13.2.4 Roche Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Merck
  13.3.1 Merck Company Details
  13.3.2 Merck Business Overview and Its Total Revenue
  13.3.3 Merck Hodgkin's Lymphoma Drugs Introduction
  13.3.4 Merck Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020)
  13.3.5 Merck Recent Development
13.4 Bristol-Myers Squibb
  13.4.1 Bristol-Myers Squibb Company Details
  13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.4.3 Bristol-Myers Squibb Hodgkin's Lymphoma Drugs Introduction
  13.4.4 Bristol-Myers Squibb Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020)
  13.4.5 Bristol-Myers Squibb Recent Development
13.5 Ono Pharmaceutical
  13.5.1 Ono Pharmaceutical Company Details
  13.5.2 Ono Pharmaceutical Business Overview and Its Total Revenue
  13.5.3 Ono Pharmaceutical Hodgkin's Lymphoma Drugs Introduction
  13.5.4 Ono Pharmaceutical Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020)
  13.5.5 Ono Pharmaceutical Recent Development
13.6 Seattle Genetics
  13.6.1 Seattle Genetics Company Details
  13.6.2 Seattle Genetics Business Overview and Its Total Revenue
  13.6.3 Seattle Genetics Hodgkin's Lymphoma Drugs Introduction
  13.6.4 Seattle Genetics Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020)
  13.6.5 Seattle Genetics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Hodgkin's Lymphoma Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Hodgkin's Lymphoma Drugs Revenue
Table 3. Ranking of Global Top Hodgkin's Lymphoma Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hodgkin's Lymphoma Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Chemotherapy
Table 7. COVID-19 Impact Global Market: (Four Hodgkin's Lymphoma Drugs Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Hodgkin's Lymphoma Drugs Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Hodgkin's Lymphoma Drugs Players to Combat Covid-19 Impact
Table 12. Global Hodgkin's Lymphoma Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Hodgkin's Lymphoma Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Hodgkin's Lymphoma Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Hodgkin's Lymphoma Drugs Market Share by Regions (2015-2020)
Table 16. Global Hodgkin's Lymphoma Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Hodgkin's Lymphoma Drugs Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Hodgkin's Lymphoma Drugs Market Growth Strategy
Table 22. Main Points Interviewed from Key Hodgkin's Lymphoma Drugs Players
Table 23. Global Hodgkin's Lymphoma Drugs Revenue by Players (2015-2020) (Million US$)
Table 24. Global Hodgkin's Lymphoma Drugs Market Share by Players (2015-2020)
Table 25. Global Top Hodgkin's Lymphoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin's Lymphoma Drugs as of 2019)
Table 26. Global Hodgkin's Lymphoma Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Hodgkin's Lymphoma Drugs Product Solution and Service
Table 29. Date of Enter into Hodgkin's Lymphoma Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 32. Global Hodgkin's Lymphoma Drugs Market Size Share by Type (2015-2020)
Table 33. Global Hodgkin's Lymphoma Drugs Revenue Market Share by Type (2021-2026)
Table 34. Global Hodgkin's Lymphoma Drugs Market Size Share by Application (2015-2020)
Table 35. Global Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 36. Global Hodgkin's Lymphoma Drugs Market Size Share by Application (2021-2026)
Table 37. North America Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 39. North America Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 40. North America Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 41. North America Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. North America Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 43. Europe Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 45. Europe Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 47. Europe Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 49. China Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 50. China Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 51. China Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. China Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 53. China Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. China Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 55. Japan Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 57. Japan Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 59. Japan Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 63. Southeast Asia Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 65. Southeast Asia Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 67. India Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 68. India Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 69. India Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. India Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 71. India Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. India Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Hodgkin's Lymphoma Drugs Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Hodgkin's Lymphoma Drugs Market Share (2019-2020)
Table 75. Central & South America Hodgkin's Lymphoma Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Hodgkin's Lymphoma Drugs Market Share by Type (2015-2020)
Table 77. Central & South America Hodgkin's Lymphoma Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Hodgkin's Lymphoma Drugs Market Share by Application (2015-2020)
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 88. Roche Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Bristol-Myers Squibb Company Details
Table 95. Bristol-Myers Squibb Business Overview
Table 96. Bristol-Myers Squibb Product
Table 97. Bristol-Myers Squibb Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Ono Pharmaceutical Company Details
Table 100. Ono Pharmaceutical Business Overview
Table 101. Ono Pharmaceutical Product
Table 102. Ono Pharmaceutical Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 103. Ono Pharmaceutical Recent Development
Table 104. Seattle Genetics Company Details
Table 105. Seattle Genetics Business Overview
Table 106. Seattle Genetics Product
Table 107. Seattle Genetics Revenue in Hodgkin's Lymphoma Drugs Business (2015-2020) (Million US$)
Table 108. Seattle Genetics Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Hodgkin's Lymphoma Drugs Market Share by Type: 2020 VS 2026
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Hodgkin's Lymphoma Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Hodgkin's Lymphoma Drugs Report Years Considered
Figure 9. Global Hodgkin's Lymphoma Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Hodgkin's Lymphoma Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Hodgkin's Lymphoma Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Hodgkin's Lymphoma Drugs Market Share by Players in 2019
Figure 14. Global Top Hodgkin's Lymphoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hodgkin's Lymphoma Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Hodgkin's Lymphoma Drugs Revenue in 2019
Figure 16. North America Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Hodgkin's Lymphoma Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 27. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Merck Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 29. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bristol-Myers Squibb Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 31. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Ono Pharmaceutical Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 33. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Seattle Genetics Revenue Growth Rate in Hodgkin's Lymphoma Drugs Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed